The crocin market size was estimated at US$ 4,546.84 million in 2022 it is predicted to grow at a CAGR of 5.16% from 2023 to 2032 to reach around US$ 7,519.96 million by the end of 2032.
The crocin market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global crocin market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global crocin market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40209
Report Scope of the Crocin Market
| Report Coverage | Details |
| Market Size in 2022 | USD 4,546.84 million |
| Revenue Forecast by 2032 | USD 7,519.96 million |
| Growth rate from 2023 to 2032 | CAGR of 5.16% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | TCI Chemicals Pvt. Ltd.; Merck KGaA; GSK plc.; Cayman Chemical; APExBIO Technology; Wilshire Technologies; Biosynth, Cipla, Inc.; Novartis AG; Sanofi; Aurobindo Pharma; Teva Pharmaceutical Industries Ltd.; Mallinckrodt |
This study covers an elaborate segmentation of the global crocin market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global crocin market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Market Segmentation
By Application
- Food
- Chemical Industry
- Drug
- Others
By Purity
- Purity >98%
- Purity <98%
By Indication
- Pain
- Pyrexia (Fever)
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
By Regional
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Research Methodology
The research methodology acquire by analysts for assemble the global crocin market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global crocin market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Crocin Market
5.1. COVID-19 Landscape: Crocin Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Crocin Market, By Application
8.1. Crocin Market, by Application, 2023-2032
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Chemical Industry
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Drug
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Crocin Market, By Purity
9.1. Crocin Market, by Purity, 2023-2032
9.1.1. Purity >98%
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Purity <98%
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Crocin Market, By Indication
10.1. Crocin Market, by Indication, 2023-2032
10.1.1. Pain
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Pyrexia (Fever)
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Crocin Market, By Distribution Channel
11.1. Crocin Market, by Distribution Channel, 2023-2032
11.1.1. Hospital Pharmacy
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Retail Pharmacy
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Crocin Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.2. Market Revenue and Forecast, by Purity (2020-2032)
12.1.3. Market Revenue and Forecast, by Indication (2020-2032)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Purity (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Indication (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.2. Market Revenue and Forecast, by Purity (2020-2032)
12.2.3. Market Revenue and Forecast, by Indication (2020-2032)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Purity (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Indication (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Purity (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Indication (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Purity (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Indication (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.2. Market Revenue and Forecast, by Purity (2020-2032)
12.3.3. Market Revenue and Forecast, by Indication (2020-2032)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Purity (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Indication (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Purity (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Indication (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Purity (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Indication (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.2. Market Revenue and Forecast, by Purity (2020-2032)
12.4.3. Market Revenue and Forecast, by Indication (2020-2032)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Purity (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Indication (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Purity (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Indication (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Purity (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Indication (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Purity (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Indication (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Purity (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Indication (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
Chapter 13. Company Profiles
13.1. TCI Chemicals Pvt. Ltd.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Merck KGaA
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GSK plc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cayman Chemical
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. APExBIO Technology
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Wilshire Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Biosynth
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cipla, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Novartis AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Sanofi
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168